Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis.

MLA

Mau, Ted, et al. “Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis.” Laryngoscope, vol. 133, no. 11, Nov. 2023, pp. 3087–93. EBSCOhost, https://doi.org/10.1002/lary.30749.

APA

Mau, T., Amin, M. R., Belafsky, P. C., Best, S. R., Friedman, A. D., Klein, A. M., Lott, D. G., Paniello, R. C., Pransky, S. M., Saba, N. F., Howard, T., Dallas, M., Patel, A., Morrow, M. P., & Skolnik, J. M. (2023). Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis. Laryngoscope, 133(11), 3087–3093. https://doi.org/10.1002/lary.30749

Chicago

Mau, Ted, Milan R. Amin, Peter C. Belafsky, Simon R. Best, Aaron D. Friedman, Adam M. Klein, David G. Lott, et al. 2023. “Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis.” Laryngoscope 133 (11): 3087–93. doi:10.1002/lary.30749.